LEADINGEDGE PHARMTOX, LLC

LEADINGEDGE PHARMTOX, LLC specializes in advanced toxicology consulting services focused on reproductive science, delivering science-driven risk assessments and regulatory support to federal health agencies. Their core capabilities center on non-clinical toxicological evaluation, reproductive and developmental toxicology study design, and interpretation of preclinical data to inform public health policy. The firm applies rigorous scientific methodologies to assess endocrine disruption, fetal toxicity, and reproductive system impacts of pharmaceuticals and environmental agents, ensuring compliance with OECD guidelines and EPA/CDER regulatory frameworks. Their differentiation lies in deep domain expertise in reproductive toxicology, bridging laboratory findings with translational health outcomes for regulatory decision-making. The contractor maintains a focused relationship with the Department of Health and Human Services, providing specialized toxicology consulting that supports research initiatives within agencies such as the National Institutes of Health and the Food and Drug Administration. Their work directly informs safety evaluations for reproductive health interventions, maternal-fetal pharmacology, and chemical exposure risk modeling, establishing a pattern of trusted, mission-critical scientific support. Operating under NAICS 541690, LEADINGEDGE PHARMTOX positions itself as a niche provider of scientific and technical consulting within the federal biomedical research ecosystem. Their industry focus is squarely on reproductive toxicology and pharmaceutical safety assessment, serving the growing demand for specialized expertise in developmental and reproductive health sciences. They serve as a high-integrity, science-first partner for agencies requiring precise, defensible toxicological analysis. As a small business structured as a 2J entity based in Kearney, Missouri, LEADINGEDGE PHARMTOX operates with agility and deep technical focus. While currently holding no formal government certifications, their reputation is built on scientific rigor and direct engagement with federal health missions. Their geographic footprint is centralized but their impact extends nationally through contracted scientific services to key HHS components.